Residual OS by POD24
| Initial management/POD24 group . | N (%) . | Event N . | 36 mo OS (95% CI) . | 60 mo OS (95% CI) . | 120 mo OS (95% CI) . | P value∗ . |
|---|---|---|---|---|---|---|
| Active treatment | 18 | <.001 | ||||
| Progression-free at 24 mo | 57 (64%) | 100% (100%-100%) | 97% (90%-100%) | 86% (74%-100%) | ||
| Progression within 24 mo | 32 (36%) | 80% (68%-96%) | 71% (55%-91%) | 56% (37%-85%) | ||
| Observation | 15 | .046 | ||||
| Progression-free at 24 mo | 53 (65%) | 98% (94%-100%) | 93% (85%-100%) | 76% (59%-97%) | ||
| Progression within 24 mo | 28 (35%) | 88% (75%-100%) | 82% (67%-100%) | 59% (38%-92%) |
| Initial management/POD24 group . | N (%) . | Event N . | 36 mo OS (95% CI) . | 60 mo OS (95% CI) . | 120 mo OS (95% CI) . | P value∗ . |
|---|---|---|---|---|---|---|
| Active treatment | 18 | <.001 | ||||
| Progression-free at 24 mo | 57 (64%) | 100% (100%-100%) | 97% (90%-100%) | 86% (74%-100%) | ||
| Progression within 24 mo | 32 (36%) | 80% (68%-96%) | 71% (55%-91%) | 56% (37%-85%) | ||
| Observation | 15 | .046 | ||||
| Progression-free at 24 mo | 53 (65%) | 98% (94%-100%) | 93% (85%-100%) | 76% (59%-97%) | ||
| Progression within 24 mo | 28 (35%) | 88% (75%-100%) | 82% (67%-100%) | 59% (38%-92%) |
The bold values are statistically significant (p values less than 0.05).
Log-rank test.